- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- July 2023
- 129 Pages
Global
From €7251EUR$7,500USD£6,228GBP
- Report
- December 2023
- 117 Pages
Global
From €10630EUR$10,995USD£9,130GBP
- Report
- April 2019
- 208 Pages
Global
From €2899EUR$2,999USD£2,490GBP
- Report
- February 2021
- 420 Pages
United States
From €2320EUR$2,400USD£1,993GBP
- Report
- September 2021
- 40 Pages
China
From €2514EUR$2,600USD£2,159GBP
- Report
- March 2019
- 16 Pages
Global
€9668EUR$10,000USD£8,304GBP
- Report
- March 2021
- 120 Pages
Global
From €10630EUR$10,995USD£9,130GBP
Lexapro is a medication used to treat mental disorders such as depression, anxiety, and panic disorder. It is a selective serotonin reuptake inhibitor (SSRI) and is one of the most commonly prescribed medications for these conditions. Lexapro works by increasing the amount of serotonin, a neurotransmitter, in the brain. This helps to improve mood, reduce anxiety, and improve overall functioning.
Lexapro is part of a larger market of mental disorder drugs, which includes other SSRIs, antipsychotics, and mood stabilizers. These medications are used to treat a variety of mental health conditions, including depression, bipolar disorder, schizophrenia, and anxiety disorders.
The companies in the Lexapro market include Forest Laboratories, Inc., Pfizer, Inc., GlaxoSmithKline, and Eli Lilly and Company. Show Less Read more
